Consensul EAS-EFLM privind evaluarea lipoproteinelor aterogene în managementul dislipidemiilor: o sinteză a recomandărilor

1 Di Cesare M, Perel P, Taylor S, Kabudula C, Bixby H, Gaziano TA, et al. The Heart of the World. Glob Heart. 2024;19(1):11-23. DOI: 10.5334/gh.1288 Search in Google Scholar

2 Pirillo A, Casula M, Olmastroni E, Norata GD, Catapano AL. Global epidemiology of dyslipidaemias. Nat Rev Cardiol. 2021;18(10):689-700. DOI: 10.1038/s41569-021-00541-4 Search in Google Scholar

3 Popa S, Mota M, Popa A, Mota E, Timar R, Serafinceanu C, et al. Prevalence of dyslipidemia and its association with cardiometabolic factors and kidney function in the adult Romanian population: The PREDATORR study. Diabetes Metab Syndr. 2019;13(1):596-602. DOI: 10.1016/j.dsx.2018.11.033 Search in Google Scholar

4 Ginsberg HN, Packard CJ, Chapman MJ, Borén J, Aguilar-Salinas CA, Averna M, et al. Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society. Eur Heart J. 2021;42(47):4791-4806. doi: 10.1093/eurheartj/ehab551. DOI: 10.1093/eurheartj/ehab551 Search in Google Scholar

5 Laufs U, Parhofer KG, Ginsberg HN, Hegele RA. Clinical review on triglycerides. Eur Heart J. 2020;41(1):99-109c. DOI: 10.1093/eurheartj/ehz785 Search in Google Scholar

6 Langlois MR, Nordestgaard BG, Langsted A, Chapman MJ, Aakre KM, Baum H, et al. Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM. Clin Chem Lab Med. 2020;58(4):496-517. DOI: 10.1515/cclm-2019-1253 Search in Google Scholar

7 Nordestgaard BG, Langsted A, Mora S, Kolovou G, Baum H, Bruckert E, et al. Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine. Eur Heart J. 2016;37(25):1944-58. DOI: 10.1093/eurheartj/ehw152 Search in Google Scholar

8 EFLM Biological Variation Database. https://biologicalvariation.eu/. Accessed 27 April 2025. Search in Google Scholar

9 Sampson M, Ling C, Sun Q, Harb R, Ashmaig M, Warnick R, et al. A New Equation for Calculation of Low-Density Lipoprotein Cholesterol in Patients With Normolipidemia and/or Hypertriglyceridemia. JAMA Cardiol. 2020;5(5):540-548. DOI: 10.1001/jamacardio.2020.0013 Search in Google Scholar

10 Sajja A, Park J, Sathiyakumar V, Varghese B, Pallazola VA, Marvel FA, et al. Comparison of Methods to Estimate Low-Density Lipoprotein Cholesterol in Patients With High Triglyceride Levels. JAMA Netw Open. 2021;4(10):e2128817. DOI: 10.1001/jamanetworkopen.2021.28817 Search in Google Scholar